Cabaletta Confident It Will Put Philly on the Biotech Map
Company IPO raised $75 million, which will help fund first clinical trialRelated Stocks: CABA,.....»»
Spark co-founder, Harvard professor launch Watertown biotech with $54M
The Watertown startup has an ambitious goal of developing vaccines that provide lifelong protection from cancer and infectious diseases......»»
Missouri initiative campaigns confident of achieving signature goals
Three initiative campaigns say they are on track to submit signatures that would put measures to legalize abortion and sports wagering, and to increase the minimum wage, on Missouri’s ballot this year. Campaign finance reports filed this week show m.....»»
Wall Street Experts Dismiss Rate Cut Fears, Middle East Tensions, Predict Bull Market"s Continuation
Despite recent concerns, Wall Street veterans are confident that the bull market will persist, citing a robust U.S. economy and the potential of artificial intelligence (AI) as key drivers. read more.....»»
Adaptive Biotechnologies names new CFO, restructures business lines
The Seattle-based biotech is looking to make its two internal businesses more independent from each other......»»
The Biotech Rebound Is Just Beginning
Health care and biotech stocks are poised to take off in the years to come, thanks to new technologies and medicines......»»
RTP firm sells more assets after struggling to raise money
The cash-strapped biotech is selling more assets after last year telling state officials it may have to lay off its entire staff......»»
Viewpoint: To stay on top, Boston must lead pharma’s transformation
Even as Boston takes pride in its status as the world’s largest biotech hub, it faces fierce and growing competition. Raleigh-Durham has long been seen as a threat to Greater Boston’s biotech dominance. But what it will really take for Bosto.....»»
Boston company to buy Alpine Immune Sciences for $4.9B
The Seattle biotech is developing a drug to treat kidney disease......»»
Seattle biotech research hub launches with big goals for growth, scientific advances
The hub — launched by the Allen Institute, UW and the Chan Zuckerberg Initiative — aims to supercharge what we can learn from human cells......»»
Execs at RDU"s big airlines increasingly confident of faster recovery for business travel
The dramatic shift toward optimism for a faster-than-expected recovery in the airline industry is accelerating......»»
JPMorgan large cap biotech analyst holds an analyst/industry conference call
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fountain Innovation Fund invests in biotech startup
Maggie Kenefake.....»»
Moleculin Biotech cleared to initiate Phase 1b/2 trial evaluating Annamycin
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Trinity Biotech reports Q1 adjusted EPS 10.1c vs. 5.3c last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Column: California"s stem cell program found a disease cure, but it"s being blocked by a biotech firm
A biotech firm has halted work on a state-funded disease cure, purely for its bottom line.A biotech firm has halted work on a state-funded disease cure, purely for its bottom line......»»
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts. read more.....»»
Sysco CEO: We"re very confident we can increase our share of wallet
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Evaxion Biotech management to meet virtually with Oppenheimer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Daily Biotech Pulse: Moderna"s Vaccine Authorized In Japan, Neovasc"s Adverse Ruling In Germany, Metacrine Rallies On Insider Buying
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) read more.....»»
Biotech Firm Launches SPAC To Buy Back SPAC At Massive Premium
Biotech Firm Launches SPAC To Buy Back SPAC At Massive Premium There's no question that the SPAC frenzy has slowed substantially from its frenzied peak late last year, but even as the pace .....»»